The Director in Epidemiology will support epidemiological strategy for programs led by the Epidemiology Cluster Head- Bacterial vaccines. The goal is to ensure high quality and on-time delivery of epidemiology data that will allow and support world-wide registration in compliance with the epidemiology plan, applicable good practices, and non-interventional studies standard operating procedures (SOP).  

As a Director in Epidemiology, you will provide scientific leadership in the application of epidemiological expertise and methods to answer key challenges identified across all phases of vaccine development for an asset or disease area to deliver new vaccines more efficiently and effectively to patients.

This position functions within the Epidemiology Department, the organization of the Chief Medical Officer, GSK R&D; which contributes to the successful development of new vaccines. Our staff in Epidemiology provide leadership and expertise to develop and execute the Epidemiology strategy across the entire spectrum of vaccine development, from early discovery to registration and lifecycle management.

This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…

• Strategic planning and expanding of epidemiology plans for vaccine development, based on technical expertise in epidemiology and the disease area.
• Drive disease understanding relevant to vaccine development:  incidence, prevalence, risk factors, natural history course, co-morbidities, co-medications/vaccinations, outcome measures, serotypes, biomarkers, unmet needs, and their variations across domains such as demographics and geographies.
• Be accountable to advise scientifically on Real World Evidence strategies.
• Contribute to medication safety evaluation: provide background event rates, synthesize existing evidence including through meta-analyses, identify high-risk populations.
• Propose and lead post-marketing studies: risk evaluation mitigation strategies, epidemiology studies for safety surveillance and inference, post-authorization studies supporting the benefit/risk evaluation.
• Critically appraise existing epidemiology evidence and create new evidence through delivery of specific research plans/protocols and analysis of healthcare databases available within GSK.
• Develop strong partnerships with internal stakeholders in a multi-disciplinary framework (clinical, safety, regulatory, and other stakeholders) to meet vaccine needs.  
• Plan resource allocation to accomplish multiple research projects and attain project and study timelines.
• Identify innovative, timely and cost-effective methods to conduct epidemiologic studies.
• Negotiate internal funding of projects.
• Develop and negotiate research plans with external collaborators in academia or contract research organizations and work effectively with vendors for outsourced studies.
• Communicate study findings to relevant internal and external audiences effectively.    
• Input into regulatory submission documents and represent the function to regulatory agencies as required.
• Present the company position on epidemiology issues and epidemiology findings to regulatory agencies and other external authorities.
• Extend a track record of external publications in peer reviewed journals in support of asset teams.
• Strengthen the position of the Epidemiology group as a recognized leader in the application of epidemiology to bacterial vaccines research and development.

 Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• Doctoral degree (PhD., ScD or DrPH) in epidemiology or a relevant discipline (i.e. health services research, health outcomes research, public health, statistics, or pharmaceutical sciences)
• Minimum of 5 years of relevant experience
• Experience leading pharmaco-epidemiologic research in a vaccine development environment.

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• Experience in infectious disease epidemiology including bacterial infections such as invasive meningitis disease (IMD) caused by Neisseria meningitidis /and vaccines.
• Excellent oral and written communication skills and demonstrated ability to communicate scientific evidence to peers and at scientific meetings.
• Good knowledge on nasopharyngeal bacterial (including Neisseria meningococcal) carriage and antimicrobial susceptibility/resistance (AMR) towards bacterial infections including Neisseria meningococcal infections.
• Self-motivated with the abil